FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (NYSE Amex LLC: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today reported financial results for the year ended December 31, 2008. For the year ended December 31, 2008, the Company reported a net loss of $9.6 million, or $0.16 cents per share, compared to a net loss of $17.0 million, or $0.29 cents per share, for the year ended December 31, 2007. Cash and cash equivalents totaled $4.3 million at December 31, 2008.
